ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in February 2024. Updated February 29.
A roundup of FDA’s actions in February 2024.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in February 2024. Updated February 29.
A roundup of FDA’s actions in February 2024.